Literature DB >> 25385641

Sample processing obscures cancer-specific alterations in leukemic transcriptomes.

Heidi Dvinge1, Rhonda E Ries2, Janine O Ilagan1, Derek L Stirewalt2, Soheil Meshinchi3, Robert K Bradley4.   

Abstract

Substantial effort is currently devoted to identifying cancer-associated alterations using genomics. Here, we show that standard blood collection procedures rapidly change the transcriptional and posttranscriptional landscapes of hematopoietic cells, resulting in biased activation of specific biological pathways; up-regulation of pseudogenes, antisense RNAs, and unannotated coding isoforms; and RNA surveillance inhibition. Affected genes include common mutational targets and thousands of other genes participating in processes such as chromatin modification, RNA splicing, T- and B-cell activation, and NF-κB signaling. The majority of published leukemic transcriptomes exhibit signals of this incubation-induced dysregulation, explaining up to 40% of differences in gene expression and alternative splicing between leukemias and reference normal transcriptomes. The effects of sample processing are particularly evident in pan-cancer analyses. We provide biomarkers that detect prolonged incubation of individual samples and show that keeping blood on ice markedly reduces changes to the transcriptome. In addition to highlighting the potentially confounding effects of technical artifacts in cancer genomics data, our study emphasizes the need to survey the diversity of normal as well as neoplastic cells when characterizing tumors.

Entities:  

Keywords:  RNA splicing; batch effects; leukemia; nonsense-mediated decay

Mesh:

Substances:

Year:  2014        PMID: 25385641      PMCID: PMC4250124          DOI: 10.1073/pnas.1413374111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Expression levels for many genes in human peripheral blood cells are highly sensitive to ex vivo incubation.

Authors:  E C Baechler; F M Batliwalla; G Karypis; P M Gaffney; K Moser; W A Ortmann; K J Espe; S Balasubramanian; K M Hughes; J P Chan; A Begovich; S-Y P Chang; P K Gregersen; T W Behrens
Journal:  Genes Immun       Date:  2004-08       Impact factor: 2.676

Review 2.  Nonsense-mediated RNA decay regulation by cellular stress: implications for tumorigenesis.

Authors:  Lawrence B Gardner
Journal:  Mol Cancer Res       Date:  2010-02-23       Impact factor: 5.852

3.  Exon skipping in the ATM gene in normal individuals: the effect of blood sample storage on RT-PCR analysis.

Authors:  G W Birrell; J R Ramsay; J J Tung; M F Lavin
Journal:  Hum Mutat       Date:  2001       Impact factor: 4.878

Review 4.  Tackling the widespread and critical impact of batch effects in high-throughput data.

Authors:  Jeffrey T Leek; Robert B Scharpf; Héctor Corrada Bravo; David Simcha; Benjamin Langmead; W Evan Johnson; Donald Geman; Keith Baggerly; Rafael A Irizarry
Journal:  Nat Rev Genet       Date:  2010-09-14       Impact factor: 53.242

5.  Improvement of molecular monitoring of residual disease in leukemias by bedside RNA stabilization.

Authors:  M C Müller; K Merx; A Weisser; S Kreil; T Lahaye; R Hehlmann; A Hochhaus
Journal:  Leukemia       Date:  2002-12       Impact factor: 11.528

6.  Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.

Authors:  Roland Schmitz; Ryan M Young; Michele Ceribelli; Sameer Jhavar; Wenming Xiao; Meili Zhang; George Wright; Arthur L Shaffer; Daniel J Hodson; Eric Buras; Xuelu Liu; John Powell; Yandan Yang; Weihong Xu; Hong Zhao; Holger Kohlhammer; Andreas Rosenwald; Philip Kluin; Hans Konrad Müller-Hermelink; German Ott; Randy D Gascoyne; Joseph M Connors; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Martin D Ogwang; Steven J Reynolds; Richard I Fisher; Rita M Braziel; Raymond R Tubbs; James R Cook; Dennis D Weisenburger; Wing C Chan; Stefania Pittaluga; Wyndham Wilson; Thomas A Waldmann; Martin Rowe; Sam M Mbulaiteye; Alan B Rickinson; Louis M Staudt
Journal:  Nature       Date:  2012-08-12       Impact factor: 49.962

7.  CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia.

Authors:  Megan E McNerney; Christopher D Brown; Xiaoyue Wang; Elizabeth T Bartom; Subhradip Karmakar; Chaitanya Bandlamudi; Shan Yu; Jinkyung Ko; Barry P Sandall; Thomas Stricker; John Anastasi; Robert L Grossman; John M Cunningham; Michelle M Le Beau; Kevin P White
Journal:  Blood       Date:  2012-12-03       Impact factor: 22.113

8.  Detecting and correcting systematic variation in large-scale RNA sequencing data.

Authors:  Sheng Li; Paweł P Łabaj; Paul Zumbo; Peter Sykacek; Wei Shi; Leming Shi; John Phan; Po-Yen Wu; May Wang; Charles Wang; Danielle Thierry-Mieg; Jean Thierry-Mieg; David P Kreil; Christopher E Mason
Journal:  Nat Biotechnol       Date:  2014-08-24       Impact factor: 54.908

9.  Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia.

Authors:  Julia A Meyer; Jinhua Wang; Laura E Hogan; Jun J Yang; Smita Dandekar; Jay P Patel; Zuojian Tang; Paul Zumbo; Sheng Li; Jiri Zavadil; Ross L Levine; Timothy Cardozo; Stephen P Hunger; Elizabeth A Raetz; William E Evans; Debra J Morrison; Christopher E Mason; William L Carroll
Journal:  Nat Genet       Date:  2013-02-03       Impact factor: 38.330

10.  Comprehensive analysis of transcriptome variation uncovers known and novel driver events in T-cell acute lymphoblastic leukemia.

Authors:  Zeynep Kalender Atak; Valentina Gianfelici; Gert Hulselmans; Kim De Keersmaecker; Arun George Devasia; Ellen Geerdens; Nicole Mentens; Sabina Chiaretti; Kaat Durinck; Anne Uyttebroeck; Peter Vandenberghe; Iwona Wlodarska; Jacqueline Cloos; Robin Foà; Frank Speleman; Jan Cools; Stein Aerts
Journal:  PLoS Genet       Date:  2013-12-19       Impact factor: 5.917

View more
  42 in total

1.  DUX4 Suppresses MHC Class I to Promote Cancer Immune Evasion and Resistance to Checkpoint Blockade.

Authors:  Guo-Liang Chew; Amy E Campbell; Emma De Neef; Nicholas A Sutliff; Sean C Shadle; Stephen J Tapscott; Robert K Bradley
Journal:  Dev Cell       Date:  2019-07-18       Impact factor: 12.270

2.  Is DNA a better assay for residual disease in chronic myeloid leukemia?

Authors:  Jerald Radich
Journal:  Haematologica       Date:  2018-11-30       Impact factor: 9.941

3.  Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells.

Authors:  Sujatha Jagannathan; Sean C Shadle; Rebecca Resnick; Lauren Snider; Rabi N Tawil; Silvère M van der Maarel; Robert K Bradley; Stephen J Tapscott
Journal:  Hum Mol Genet       Date:  2016-10-15       Impact factor: 6.150

Review 4.  Mass Cytometry: Single Cells, Many Features.

Authors:  Matthew H Spitzer; Garry P Nolan
Journal:  Cell       Date:  2016-05-05       Impact factor: 41.582

5.  DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia.

Authors:  Christopher C Oakes; Marc Seifert; Yassen Assenov; Lei Gu; Martina Przekopowitz; Amy S Ruppert; Qi Wang; Charles D Imbusch; Andrius Serva; Sandra D Koser; David Brocks; Daniel B Lipka; Olga Bogatyrova; Dieter Weichenhan; Benedikt Brors; Laura Rassenti; Thomas J Kipps; Daniel Mertens; Marc Zapatka; Peter Lichter; Hartmut Döhner; Ralf Küppers; Thorsten Zenz; Stephan Stilgenbauer; John C Byrd; Christoph Plass
Journal:  Nat Genet       Date:  2016-01-18       Impact factor: 38.330

6.  Disease Characteristics and Prognostic Implications of Cell-Surface FLT3 Receptor (CD135) Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group.

Authors:  Katherine Tarlock; Todd A Alonzo; Michael R Loken; Robert B Gerbing; Rhonda E Ries; Richard Aplenc; Lillian Sung; Susana C Raimondi; Betsy A Hirsch; Samir B Kahwash; Amy McKenney; E Anders Kolb; Alan S Gamis; Soheil Meshinchi
Journal:  Clin Cancer Res       Date:  2017-01-20       Impact factor: 12.531

Review 7.  Systems vaccinology: a promise for the young and the poor.

Authors:  Nelly Amenyogbe; Ofer Levy; Tobias R Kollmann
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-06-19       Impact factor: 6.237

8.  Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene Mutations.

Authors:  Stanley Chun-Wei Lee; Khrystyna North; Eunhee Kim; Eunjung Jang; Esther Obeng; Sydney X Lu; Bo Liu; Daichi Inoue; Akihide Yoshimi; Michelle Ki; Mirae Yeo; Xiao Jing Zhang; Min Kyung Kim; Hana Cho; Young Rock Chung; Justin Taylor; Benjamin H Durham; Young Joon Kim; Alessandro Pastore; Sebastien Monette; James Palacino; Michael Seiler; Silvia Buonamici; Peter G Smith; Benjamin L Ebert; Robert K Bradley; Omar Abdel-Wahab
Journal:  Cancer Cell       Date:  2018-08-13       Impact factor: 31.743

9.  The effects of sample handling on proteomics assessed by reverse phase protein arrays (RPPA): Functional proteomic profiling in leukemia.

Authors:  Terzah M Horton; Fieke W Hoff; Anneke van Dijk; Gaye N Jenkins; Debra Morrison; Teena Bhatla; Laura Hogan; Eleny Romanos-Sirakis; Julia Meyer; William L Carroll; Yihua Qiu; Tao Wang; Qianxing Mo; Steven M Kornblau
Journal:  J Proteomics       Date:  2020-11-16       Impact factor: 4.044

10.  Minor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition.

Authors:  Daichi Inoue; Jacob T Polaski; Justin Taylor; Pau Castel; Sisi Chen; Susumu Kobayashi; Simon J Hogg; Yasutaka Hayashi; Jose Mario Bello Pineda; Ettaib El Marabti; Caroline Erickson; Katherine Knorr; Miki Fukumoto; Hiromi Yamazaki; Atsushi Tanaka; Chie Fukui; Sydney X Lu; Benjamin H Durham; Bo Liu; Eric Wang; Sanjoy Mehta; Daniel Zakheim; Ralph Garippa; Alex Penson; Guo-Liang Chew; Frank McCormick; Robert K Bradley; Omar Abdel-Wahab
Journal:  Nat Genet       Date:  2021-04-12       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.